128 related articles for article (PubMed ID: 9264501)
1. Novel low-molecular-weight inhibitor of PAI-1 (XR5118) promotes endogenous fibrinolysis and reduces postthrombolysis thrombus growth in rabbits.
Friederich PW; Levi M; Biemond BJ; Charlton P; Templeton D; van Zonneveld AJ; Bevan P; Pannekoek H; ten Cate JW
Circulation; 1997 Aug; 96(3):916-21. PubMed ID: 9264501
[TBL] [Abstract][Full Text] [Related]
2. Thrombolysis and reocclusion in experimental jugular vein and coronary artery thrombosis. Effects of a plasminogen activator inhibitor type 1-neutralizing monoclonal antibody.
Biemond BJ; Levi M; Coronel R; Janse MJ; ten Cate JW; Pannekoek H
Circulation; 1995 Feb; 91(4):1175-81. PubMed ID: 7850956
[TBL] [Abstract][Full Text] [Related]
3. Identification of the binding site for a low-molecular-weight inhibitor of plasminogen activator inhibitor type 1 by site-directed mutagenesis.
Björquist P; Ehnebom J; Inghardt T; Hansson L; Lindberg M; Linschoten M; Strömqvist M; Deinum J
Biochemistry; 1998 Feb; 37(5):1227-34. PubMed ID: 9477948
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of a low molecular weight modulator of human plasminogen activator inhibitor-1 activity.
Charlton PA; Faint RW; Bent F; Bryans J; Chicarelli-Robinson I; Mackie I; Machin S; Bevan P
Thromb Haemost; 1996 May; 75(5):808-15. PubMed ID: 8725728
[TBL] [Abstract][Full Text] [Related]
5. Phosphorothioate oligodeoxyribonucleotides antisense to PAI-1 mRNA increase fibrinolysis and modify experimental thrombosis in rats.
Pawlowska Z; Pluskota E; Chabielska E; Buczko W; Okruszek A; Stec WJ; Cierniewski CS
Thromb Haemost; 1998 Feb; 79(2):348-53. PubMed ID: 9493589
[TBL] [Abstract][Full Text] [Related]
6. The composition of complexes between plasminogen activator inhibitor 1, vitronectin and either thrombin or tissue-type plasminogen activator.
van Meijer M; Stoop A; Smilde A; Preissner KT; van Zonneveld AJ; Pannekoek H
Thromb Haemost; 1997 Mar; 77(3):516-21. PubMed ID: 9066004
[TBL] [Abstract][Full Text] [Related]
7. Less pronounced enhancement of thrombin-dependent inactivation of plasminogen activator inhibitor type 1 by low molecular weight heparin compared with unfractionated heparin.
Nakamura R; Umemura K; Hashimmoto H; Urano T
Thromb Haemost; 2006 Apr; 95(4):637-42. PubMed ID: 16601834
[TBL] [Abstract][Full Text] [Related]
8. Biochemical mechanism of action of a diketopiperazine inactivator of plasminogen activator inhibitor-1.
Einholm AP; Pedersen KE; Wind T; Kulig P; Overgaard MT; Jensen JK; Bødker JS; Christensen A; Charlton P; Andreasen PA
Biochem J; 2003 Aug; 373(Pt 3):723-32. PubMed ID: 12723974
[TBL] [Abstract][Full Text] [Related]
9. Characterization and comparative evaluation of a novel PAI-1 inhibitor.
Gils A; Stassen JM; Nar H; Kley JT; Wienen W; Ries UJ; Declerck PJ
Thromb Haemost; 2002 Jul; 88(1):137-43. PubMed ID: 12152654
[TBL] [Abstract][Full Text] [Related]
10. TM5275 prolongs secreted tissue plasminogen activator retention and enhances fibrinolysis on vascular endothelial cells.
Yasui H; Suzuki Y; Sano H; Suda T; Chida K; Dan T; Miyata T; Urano T
Thromb Res; 2013 Jul; 132(1):100-5. PubMed ID: 23611258
[TBL] [Abstract][Full Text] [Related]
11. A novel inhibitor of activated thrombin activatable fibrinolysis inhibitor (TAFIa) - part II: enhancement of both exogenous and endogenous fibrinolysis in animal models of thrombosis.
Wang YX; da Cunha V; Vincelette J; Zhao L; Nagashima M; Kawai K; Yuan S; Emayan K; Islam I; Hosoya J; Sullivan ME; Dole WP; Morser J; Buckman BO; Vergona R
Thromb Haemost; 2007 Jan; 97(1):54-61. PubMed ID: 17200771
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of endothelial cell expression of plasminogen activator inhibitor type-1 by gemfibrozil.
Fujii S; Sawa H; Sobel BE
Thromb Haemost; 1993 Oct; 70(4):642-7. PubMed ID: 7509512
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of PAI-039 [{1-benzyl-5-[4-(trifluoromethoxy)phenyl]-1H-indol-3-yl}(oxo)acetic acid], a novel plasminogen activator inhibitor-1 inhibitor, in a canine model of coronary artery thrombosis.
Hennan JK; Elokdah H; Leal M; Ji A; Friedrichs GS; Morgan GA; Swillo RE; Antrilli TM; Hreha A; Crandall DL
J Pharmacol Exp Ther; 2005 Aug; 314(2):710-6. PubMed ID: 15860572
[TBL] [Abstract][Full Text] [Related]
14. Characterization of a small molecule PAI-1 inhibitor, ZK4044.
Liang A; Wu F; Tran K; Jones SW; Deng G; Ye B; Zhao Z; Snider RM; Dole WP; Morser J; Wu Q
Thromb Res; 2005; 115(4):341-50. PubMed ID: 15668194
[TBL] [Abstract][Full Text] [Related]
15. Dose-dependent thrombus resolution due to oral plaminogen activator inhibitor (PAI)-1 inhibition with tiplaxtinin in a rat stenosis model of venous thrombosis.
Baxi S; Crandall DL; Meier TR; Wrobleski S; Hawley A; Farris D; Elokdah H; Sigler R; Schaub RG; Wakefield T; Myers D
Thromb Haemost; 2008 Apr; 99(4):749-58. PubMed ID: 18392333
[TBL] [Abstract][Full Text] [Related]
16. The Fab-fragment of a PAI-1 inhibiting antibody reduces thrombus size and restores blood flow in a rat model of arterial thrombosis.
van Giezen JJ; Wahlund G; Nerme ; Abrahamsson T
Thromb Haemost; 1997 May; 77(5):964-9. PubMed ID: 9184411
[TBL] [Abstract][Full Text] [Related]
17. The variable region-1 from tissue-type plasminogen activator confers specificity for plasminogen activator inhibitor-1 to thrombin by facilitating catalysis: release of a kinetic block by a heterologous protein surface loop.
Dekker RJ; Eichinger A; Stoop AA; Bode W; Pannekoek H; Horrevoets AJ
J Mol Biol; 1999 Oct; 293(3):613-27. PubMed ID: 10543954
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of rabbit jugular vein thrombolysis by neutralization of factor XI. In vivo evidence for a role of factor XI as an anti-fibrinolytic factor.
Minnema MC; Friederich PW; Levi M; von dem Borne PA; Mosnier LO; Meijers JC; Biemond BJ; Hack CE; Bouma BN; ten Cate H
J Clin Invest; 1998 Jan; 101(1):10-4. PubMed ID: 9421460
[TBL] [Abstract][Full Text] [Related]
19. Hyperfibrinolysis in alcoholic cirrhosis: relative plasminogen activator inhibitor type 1 deficiency.
Ferguson JW; Helmy A; Ludlam C; Webb DJ; Hayes PC; Newby DC
Thromb Res; 2008; 121(5):675-80. PubMed ID: 17870147
[TBL] [Abstract][Full Text] [Related]
20. Human thrombin and calcium bound factor Xa significantly shorten tPA-induced fibrin clot lysis time via neutralization of plasminogen activator inhibitor type 1 activity.
Urano T; Nagai N; Matsuura M; Ihara H; Takada Y; Takada A
Thromb Haemost; 1998 Jul; 80(1):161-6. PubMed ID: 9684803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
